Combination Therapy with Ampicillin and Daptomycin for Treatment of Enterococcus faecalis Endocarditis | Zendy

Miguel SierraHoffman | Zendy; Oscar Iznaola | Zendy; Mark Goodwin | Zendy; J. J. Mohr | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Combination Therapy with Ampicillin and Daptomycin for Treatment of Enterococcus faecalis Endocarditis

Author(s) -

Miguel SierraHoffman,

Oscar Iznaola,

Mark Goodwin,

J. J. Mohr

Publication year - 2012

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01760-12

Subject(s) - daptomycin , enterococcus faecalis , endocarditis , ampicillin , enterococcus , microbiology and biotechnology , medicine , antibacterial agent , antibiotics , vancomycin , biology , bacteria , staphylococcus aureus , genetics

Enterococci are identified as the causative pathogen in approximately 10 percent of infective endocarditis cases, and the most frequently isolated species are Enterococcus faecalis and Enterococcus faecium ([3][1]). Gentamicin in combination with penicillins or glycopeptides is recommended for

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research